In 2023, the re-import of electro-cardiographs to Canada stood at an actual value that predates the 2024 forecast. From 2024 onwards, the values indicate a consistent year-on-year decrease: 2.48 million USD in 2024, decreasing steadily to 2.24 million USD by 2028. This represents a steady decline, with an average compound annual growth rate (CAGR) showing a negative trend over the forecasted period.

Future trends to watch for include:

Technological advancements in cardiac monitoring devices that could impact re-import levels.
Policy changes influencing import tariffs and international trade agreements affecting medical equipment.
Health sector demands and spending on healthcare technology within Canada.